Stent studies don't reflect 'real world' patients
Stroke-preventing devices are not being tested in people who resemble the patients most likely to receive them, a new study shows. The researchers looked at tests being done as part of "post-market surveillance studies," which test products that are already approved and in general use by the public. They found that patients who had stents placed into their neck in these studies were healthier than other patients in a broader nationwide registry of people who received stents. Yet the patients in the larger registry database who weren't in the post-marketing studies were 50% more likely to have had a stroke in the past, and were four times as likely to die in the hospital.
- CFO Exchange: Smartphones Poised to Disrupt Healthcare, Says Topol
- Consumerism Drives Healthcare Branding, Rebranding Efforts
- 3 Traits Personality Assessments Can't Reveal
- PA Ranks See 'Phenomenal Growth,' Lack of Diversity
- Antibiotic Overuse a 'Huge Threat' to Patient Safety, Says CDC
- CNO on Hospital Redesign: 'You Can't Over-Communicate'
- CFO Exchange: Healthcare Leaders Share 5 Innovative Ideas
- How Digital Strategy Shapes Patient Engagement at Boston Children's Hospital
- CHS Hacked, 4.5M Patient Records Compromised
- Carondelet to Pay $35M to Settle Fraud Allegations